| COX2 |
P00403
|
cytochrome c oxidase subunit II
|
Enzyme
|
|
0.352 |
0.962 |
| MTCO2P12 |
|
MT-CO2 pseudogene 12
|
|
|
0.368 |
0.962 |
| IFNA1 |
P01562
|
interferon alpha 1
|
|
|
0.371 |
0.923 |
| IFNA13 |
P01562
|
interferon alpha 13
|
|
|
0.374 |
0.923 |
| MIR155 |
|
microRNA 155
|
|
|
0.384 |
0.885 |
| MIR146A |
|
microRNA 146a
|
|
|
0.398 |
0.885 |
| TRBV20OR9-2 |
|
T cell receptor beta variable 20/OR9-2 (non-functional)
|
|
|
0.403 |
0.923 |
| CDR3 |
|
Cerebellar degeneration-related autoantigen-3
|
|
|
0.472 |
0.808 |
| HT |
|
Hashimoto thyroiditis
|
|
|
0.505 |
0.731 |
| MRGPRX3 |
Q96LB0
|
MAS related GPR family member X3
|
G-protein coupled receptor
|
|
0.529 |
0.923 |
| VN1R17P |
Q8TDU5
|
vomeronasal 1 receptor 17 pseudogene
|
|
|
0.529 |
0.923 |
| MRGPRX4 |
Q96LA9
|
MAS related GPR family member X4
|
G-protein coupled receptor
|
|
0.531 |
0.923 |
| MRGPRX1 |
Q96LB2
|
MAS related GPR family member X1
|
G-protein coupled receptor
|
|
0.531 |
0.923 |
| GPR166P |
|
G protein-coupled receptor 166 pseudogene
|
|
|
0.531 |
0.923 |
| THAS |
|
thoracoabdominal syndrome
|
|
|
0.560 |
0.808 |
| HLA-DRB4 |
P13762
|
major histocompatibility complex, class II, DR beta 4
|
Immune response
|
|
0.565 |
0.846 |
| HPP1 |
|
hyperpigmentation, progressive, 1
|
|
|
0.686 |
0.346 |
| TTN |
Q8WZ42
|
titin
|
Kinase
|
2.6E-96 |
0.470 |
0.885 |
| TG |
P01266
|
thyroglobulin
|
Enzyme modulator
|
2.9E-59 |
0.480 |
0.808 |
| ERAP1 |
Q9NZ08
|
endoplasmic reticulum aminopeptidase 1
|
Enzyme
|
2.1E-26 |
0.556 |
0.692 |
| TPO |
P07202
|
thyroid peroxidase
|
Enzyme
|
1.8E-21 |
0.455 |
0.846 |
| PTPN22 |
Q9Y2R2
|
protein tyrosine phosphatase non-receptor type 22
|
|
3.5E-21 |
0.438 |
0.846 |
| IRAK3 |
Q9Y616
|
interleukin 1 receptor associated kinase 3
|
Kinase
|
5.3E-21 |
0.615 |
0.615 |
| CR2 |
P20023
|
complement C3d receptor 2
|
|
4.7E-19 |
0.556 |
0.654 |
| SPTA1 |
P02549
|
spectrin alpha, erythrocytic 1
|
|
2.6E-18 |
0.638 |
0.538 |